Latest Breaking News On - Swedish medical product agency - Page 1 : comparemela.com

Anocca Secures GMP Manufacturing License To Push Novel KRAS TCR-T Cell Therapies Into Clinical Development

Anocca Secures GMP Manufacturing License To Push Novel KRAS TCR-T Cell Therapies Into Clinical Development
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Hugh salterDaniel goochReagan jarvisScius communicationsSwedish medical product agencyLargest facilityClinical supplyChief scientific officer

Additive effects of booster mRNA vaccination and SARS-CoV-2 Omicron infection on T cell immunity across immunocompromised states

Additive effects of booster mRNA vaccination and SARS-CoV-2 Omicron infection on T cell immunity across immunocompromised states
science.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from science.org Daily Mail and Mail on Sunday newspapers.

United statesCryopreserved pbmcsKarolinska institutetDeutsche forschungsgemeinschaftPepscan prestoCelltrace violetFina biosolutionsJeanssons stiftelseOxford immunotecKarolinska institutet dnrM celltrace violetWibergs stiftelseSwedish ethical review authorityWorld health organizationHematology swedish blood cancer foundationSwedish research council

Adial Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Business Update

12.05.2023 - Conducted meetings with U.S. and select European regulatory agencies Received Notice of Exercise and upfront cash of $0.45 million from Advocate for the sale of Purnovate assets and business Ended 2023 first quarter with cash and cash equivalents . Seite 1

United kingdomCary claiborneAdial pharmaceuticals incSwedish medical product agencyInstitute for drugsKeswick groupDrug administrationRegulatory agencyChief executive officerFederal instituteMedical devicesAdial pharmaceuticals

Investegate |LIDDS AB Announcements | LIDDS AB: LIDDS AB (publ) Year-end report 2021

Investegate announcements from LIDDS AB, LIDDS AB (publ) Year-end report 2021

Uppsala lanNina hernePuheng pharmaNovo nordiskSwedish medical product agencyJohnson enterprise innovation incEuropean medicines agencyNice greenJohnson enterprise innovationLiproca depotCapital market dayMatthew lindonChief scientific officerProject managerVipergen apsWith nanozolid

LIDDS AB (publ) Year-end report 2021

October - December Net sales amounted to 2.4 (0.3) MSEKThe operating result for the period was -8.9 (-12.5) MSEKThe net result was -8.9 (-12.5) MSEK corresponding to earnings per share of SEK -0.26

Uppsala lanNina hernePuheng pharmaNovo nordiskSwedish medical product agencyJohnson enterprise innovation incEuropean medicines agencyLiproca depotNice greenJohnson enterprise innovationCapital market dayMatthew lindonChief scientific officerProject managerVipergen apsWith nanozolid